BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6449674)

  • 1. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between magnitude of electroshock stimulation and the effects of digitoxigenin, pentylenetetrazol and brain monoamine reduction on electroshock convulsive thresholds.
    Buterbaugh GG; London ED
    Neuropharmacology; 1977 Sep; 16(9):617-23. PubMed ID: 144247
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of monoamines in the behavioural effects of kainic acid in rats.
    Lenicque PM; Wepierre J; Cohen Y
    J Neural Transm; 1981; 51(3-4):205-12. PubMed ID: 6116744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 7. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
    Senault B
    Psychopharmacologia; 1974 Jan; 34(2):143-54. PubMed ID: 4274176
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge.
    Wilkison DM; Halpern LM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):151-8. PubMed ID: 158641
    [No Abstract]   [Full Text] [Related]  

  • 11. Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines.
    Ciarlone AE
    J Dent Res; 1981 Feb; 60(2):182-6. PubMed ID: 6450781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Convulsions and monoamines].
    Kariya T
    Nihon Rinsho; 1978; 36(1):90-4. PubMed ID: 633637
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamines modulation of morphine action on pain threshold and cortical acetylcholine outflow.
    Beani L; Siniscalchi A; Sarto G
    Pharmacol Res Commun; 1979 Sep; 11(8):663-80. PubMed ID: 160044
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholaminergic involvement in the effects of amphetamine isomers on seizure susceptibility.
    Gerald MC; Gupta TK
    Eur J Pharmacol; 1977 Jan; 41(2):231-4. PubMed ID: 832677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology.
    Richards JG; Tranzer JP
    Experientia; 1974 Mar; 30(3):287-9. PubMed ID: 4274761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 18. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):206-18. PubMed ID: 4254846
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of imipramine and synthesis inhibitors on biogenic amines.
    Friedman E; Shopsin B; Goldstein M; Gershon S
    J Pharm Pharmacol; 1974 Dec; 26(12):995-6. PubMed ID: 4156872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.